RXRX vs NVAX
Head-to-Head Stock Analysis & Investment Rating
Last Updated: May 25, 2026
RXRX
NVAX
Investment Advisor Scores
NVAX
AI Analyst Insights
Detailed Metrics Comparison
| Metric | RXRX | NVAX | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 0 | 2.5846 | Tie |
| PEG Ratio | 0 | 1.3218 | Tie |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | -56.1% | -79.1% | RXRX |
| Earnings Growth | 0.0% | -38.1% | RXRX |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 51.6/100 | 60.2/100 | NVAX |
| Profit Margin | 0.0% | -14.7% | RXRX |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | HOLD | BUY | NVAX |
Relative Price Performance (Last 90 Days)
Current Technical Phase
RXRX
NeutralMixed signals - no dominant trend phase, RSI 50
NVAX
MarkdownPrice below a falling SMA50 (slope -2.6%), weak momentum, RSI 33
Fundamentals Snapshot
| Metric | RXRX | NVAX |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | -3.4 | -29.1 |
| Trailing P/E | — | — |
| Revenue (TTM) | — | — |
| Revenue Growth | -0.6% | -0.8% |
| Gross Margin | -6.5% | 0.3% |
| Operating Margin | -19.9% | -0.1% |
| EPS | -1.16 | -0.56 |
| Dividend Yield | — | — |